Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06670001 · ClinicalTrials.gov registry record · NA
MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction
A NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT06670001: Recruiting NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, sponsored by University of Pennsylvania.
NCT06670001 is a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 270 participants, below the 9,836-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06670001, a NA study of HFpEF - Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a three-arm, randomized, controlled trial to test the effectiveness of gamification plus a social incentive - either social support or competition - to increase adherence to physical activity among individuals with HFpEF. There will be a 2-week run-in period to obtain baseline measures of physical activity, followed by a 6-month intervention period and then a 3-month follow-up period.
Primary Outcome
The primary outcome is the change in mean daily step counts from baseline through the 3-month post-intervention follow-up period.
Conditions Studied
Interventions
- BEHAVIORAL Gamification plus social incentive
- BEHAVIORAL Gamification plus competition
Study Locations (1)
Pennsylvania
- The University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2025-06-05 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What NCT06670001 shows while recruiting
NCT06670001 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 9,836-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (97% lower).
The record links to 1 condition, with HFpEF - Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 2 interventions - of which Gamification plus social incentive is the first listed.
NCT06670001 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06670001 about?
NCT06670001 is a clinical study titled "MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction". This is a three-arm, randomized, controlled trial to test the effectiveness of gamification plus a social incentive - either social support or competition - to increase adherence to physical activity among individuals with HFpEF. There will be a 2-week run-in period to obtain baseline measures of ph...
What is the current status of trial NCT06670001?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-06-05. Estimated completion is 2029-03-31.
What conditions does trial NCT06670001 study?
This clinical trial studies the following conditions: HFpEF - Heart Failure With Preserved Ejection Fraction.
What interventions are being tested in trial NCT06670001?
The interventions under investigation include: Gamification plus social incentive (BEHAVIORAL), Gamification plus competition (BEHAVIORAL).
Who is sponsoring clinical trial NCT06670001?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06670001 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HFpEF - Heart Failure With Preserved Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
RECRUITING · NA
-
US Benchmarking Clinical Study
RECRUITING
-
Tailored Exercise Training Study Among Adults With HFpEF
RECRUITING · Phase 2
-
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
RECRUITING · Phase 2
-
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
RECRUITING · Phase 2
-
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI